Abstract Submission Guidelines

The Scientific Committee invites clinicians, researchers, academicians, healthcare professionals and young investigators to submit original scientific work for presentation.

Submission Opens
1st November 2026
Submission Deadline
30th April 2027
Notification of Acceptance
31st July 2027

Presentation Formats

Based on the blinded review, accepted abstracts may be allocated to one of four presentation formats.

1. Oral Abstract Session (OAS)

Selected high-ranking abstracts will be presented as oral presentations during dedicated scientific sessions, followed by discussion with moderators and the audience.

2. Flash Talk Session (FTS)

Selected abstracts will be presented as short, focused oral presentations highlighting the key findings of the work, followed by brief discussion.

3. Thematic Poster Session (TPS)

Selected abstracts will be presented as posters. Presenters will be expected to be available at their posters and briefly present the key findings during the assigned session.

4. E-Thematic Poster Session (E-TPS)

Selected abstracts will be displayed electronically on the conference digital platform. No onsite oral presentation will be required for this category.

General Guidelines

  • Conference registration is mandatory for the presenting author of every accepted abstract, irrespective of the presentation format.
  • Abstracts must present original scientific work and/or original data generated by the author(s).
  • Review articles, literature reviews and previously published work will not be considered.
  • Abstracts must be submitted in English.
  • All abstracts must be submitted exclusively through the official Online Abstract Submission Portal.
  • The main body of the abstract must not exceed 300 words (excluding title, authors, affiliations, etc.).
  • There is no restriction on the number of abstracts submitted, but an individual may present a maximum of three accepted abstracts onsite (OAS, FTS, TPS). E-TPS do not count towards this limit.

Abstract Structure

Abstracts should be concise, scientifically relevant and structured according to the prescribed format. Each abstract should include:

Title
Author(s)
Affiliation(s)
Background
Materials and Methods
Results
Conclusion
Ethical Committee Clearance (where applicable)

Review Criteria

  • Scientific quality and originality.
  • Appropriateness of methodology.
  • Quality and completeness of results.
  • Clinical and/or scientific relevance and potential contribution to the field.

Submission Categories

Drug Allergy and Drug Hypersensitivity
Food Allergy, Eosinophilic Gastrointestinal Disorders
Asthma – Pathogenesis, Diagnosis and Management
Allergic Rhinitis, Ocular Allergy and Upper Airway Disease
Allergen Immunotherapy
Anaphylaxis and Insect Venom Allergy
Atopic Dermatitis, Urticaria, Angioedema
Primary & Secondary Immunodeficiency and Autoimmunity
Pediatric Allergy and Immunology
Allergy Diagnostics, Biomarkers and Precision Medicine
Biologics and Emerging Therapeutics in Allergy
Basic, Translational and Experimental Immunology
Aerobiology, Pollution and Climate Change
Epidemiology, Prevention and Public Health in Allergy
Artificial Intelligence, Digital Health and Innovation
Occupational Allergy
Allied Health, Primary Care and Multidisciplinary Practice
Other Topics in Allergy and Clinical Immunology

The Scientific Committee reserves the right to reassign an abstract to a different category where appropriate.

Ready to Submit?

The official Online Abstract Submission Portal will open soon. Please carefully review all submission guidelines before submitting your abstract.

Portal Opens Nov 1, 2026
Need Assistance?

Conference Secretariat
Email: Info@globalallergysummit2027.com | Phone: +91 85952 51325